Molecular targeted treatment in infants with central conducting lymphatic anomalies. - van den Brink VC; Kleimeier LER; Leenders EKSM; Klein WM; de Boode WP; Fuijkschot J; Vrancken SLAG (European journal of pediatrics, 2025)